Astrana Health (ASTH) Capital Expenditures (2011 - 2026)

Astrana Health has reported Capital Expenditures for 16 years, with the latest figure at $4.0 million in Q1 2026.

• Quarterly Capital Expenditures rose 30.29% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (up 2.83% YoY) and the FY2025 annual result came in at $10.1 million, up 25.84% from the prior year.
• Capital Expenditures improved to $4.0 million in Q1 2026 per ASTH's latest filing, from $3.1 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $17.5 million in Q1 2022 and troughed at $369000.0 in Q1 2024.
• A 5-year average of $4.3 million and a median of $3.1 million in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures soared 17745.92% in 2022, then tumbled 93.88% in 2024.
• Over 5 years, Capital Expenditures stood at $886000.0 in 2022, then jumped by 696.5% to $7.1 million in 2023, then tumbled by 64.13% to $2.5 million in 2024, then increased by 21.06% to $3.1 million in 2025, then soared by 30.55% to $4.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $4.0 million, $3.1 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.